Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QBG7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 295 | 297 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 302 | 304 | PF00675 | 0.604 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 238 | 240 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 295 | 297 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 302 | 304 | PF00082 | 0.604 |
CLV_PCSK_PC1ET2_1 | 107 | 109 | PF00082 | 0.306 |
CLV_PCSK_PC7_1 | 103 | 109 | PF00082 | 0.306 |
CLV_PCSK_PC7_1 | 291 | 297 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.235 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.263 |
DOC_CKS1_1 | 135 | 140 | PF01111 | 0.506 |
DOC_MAPK_gen_1 | 107 | 114 | PF00069 | 0.506 |
DOC_MAPK_gen_1 | 9 | 16 | PF00069 | 0.376 |
DOC_MAPK_MEF2A_6 | 107 | 114 | PF00069 | 0.517 |
DOC_MAPK_NFAT4_5 | 107 | 115 | PF00069 | 0.506 |
DOC_PP4_FxxP_1 | 327 | 330 | PF00568 | 0.504 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.496 |
DOC_USP7_MATH_1 | 60 | 64 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.500 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.506 |
DOC_WW_Pin1_4 | 225 | 230 | PF00397 | 0.607 |
LIG_14-3-3_CanoR_1 | 103 | 110 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 111 | 121 | PF00244 | 0.447 |
LIG_14-3-3_CanoR_1 | 209 | 213 | PF00244 | 0.590 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.561 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.483 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.463 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.506 |
LIG_FHA_2 | 30 | 36 | PF00498 | 0.506 |
LIG_Integrin_RGD_1 | 303 | 305 | PF01839 | 0.583 |
LIG_LIR_Apic_2 | 324 | 330 | PF02991 | 0.534 |
LIG_LIR_Gen_1 | 40 | 48 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 332 | 337 | PF02991 | 0.587 |
LIG_LIR_Nem_3 | 339 | 345 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 40 | 45 | PF02991 | 0.511 |
LIG_Pex14_1 | 281 | 285 | PF04695 | 0.524 |
LIG_PTB_Apo_2 | 95 | 102 | PF02174 | 0.483 |
LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.532 |
LIG_SH2_STAT5 | 300 | 303 | PF00017 | 0.558 |
LIG_SH3_3 | 80 | 86 | PF00018 | 0.463 |
LIG_SUMO_SIM_anti_2 | 161 | 166 | PF11976 | 0.466 |
LIG_TRAF2_1 | 91 | 94 | PF00917 | 0.477 |
MOD_CDK_SPxxK_3 | 134 | 141 | PF00069 | 0.506 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.534 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.507 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.538 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.519 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.414 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.484 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.506 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.506 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.505 |
MOD_Cter_Amidation | 236 | 239 | PF01082 | 0.523 |
MOD_Cter_Amidation | 293 | 296 | PF01082 | 0.576 |
MOD_GlcNHglycan | 120 | 124 | PF01048 | 0.214 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.764 |
MOD_GlcNHglycan | 263 | 266 | PF01048 | 0.669 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.289 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.521 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.699 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.497 |
MOD_N-GLC_1 | 103 | 108 | PF02516 | 0.317 |
MOD_N-GLC_1 | 240 | 245 | PF02516 | 0.649 |
MOD_N-GLC_1 | 74 | 79 | PF02516 | 0.306 |
MOD_N-GLC_2 | 152 | 154 | PF02516 | 0.306 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.505 |
MOD_PIKK_1 | 78 | 84 | PF00454 | 0.463 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.476 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.572 |
MOD_PKA_2 | 237 | 243 | PF00069 | 0.577 |
MOD_PKA_2 | 261 | 267 | PF00069 | 0.611 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.511 |
MOD_Plk_1 | 281 | 287 | PF00069 | 0.548 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.507 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.561 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.460 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.506 |
MOD_ProDKin_1 | 225 | 231 | PF00069 | 0.608 |
TRG_DiLeu_BaLyEn_6 | 105 | 110 | PF01217 | 0.463 |
TRG_ER_diArg_1 | 180 | 182 | PF00400 | 0.528 |
TRG_ER_diArg_1 | 301 | 303 | PF00400 | 0.578 |
TRG_Pf-PMV_PEXEL_1 | 108 | 113 | PF00026 | 0.316 |
TRG_Pf-PMV_PEXEL_1 | 170 | 174 | PF00026 | 0.214 |
TRG_Pf-PMV_PEXEL_1 | 39 | 43 | PF00026 | 0.306 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCI0 | Leptomonas seymouri | 69% | 100% |
A0A0S4IYS0 | Bodo saltans | 37% | 96% |
A0A3S7WXE9 | Leishmania donovani | 86% | 100% |
A4HCM2 | Leishmania braziliensis | 73% | 100% |
A4I046 | Leishmania infantum | 86% | 100% |
E9AW09 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |